Fapon
Fapon Biotech is a Chinese IVD company founded in 2001 that provides a vertically integrated one-stop solution spanning raw materials, reagent services, and open-system instruments, serving 2,500+ IVD manufacturers and laboratories across 70+ countries through direct sales and channel partnerships.
- Company typePrivate
- Founded2001
- HeadquartersDongguan, China
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fapon does
Fapon Biotech is a privately held Chinese in vitro diagnostics (IVD) company founded in 2001 and headquartered in Dongguan, Guangdong. The company operates a vertically integrated 'one-stop IVD total solution' model spanning three product lines: core raw materials (antigens, antibodies, diagnostic enzymes, blockers, and calibrators), customized reagent development services, and open-system instruments (notably the Shine i-Series CLIA analyzers, the Ideal 30 molecular diagnostic system, and immunofluorescence analyzers). Technology coverage spans chemiluminescence immunoassay, ELISA, rapid test, molecular diagnostics (qPCR, NGS, LAMP), and clinical chemistry. The company serves IVD reagent manufacturers, clinical laboratories, and emerging-market IVD companies across 70+ countries via 2,500+ partners, using direct field sales, industry trade shows, and channel partnerships including joint ventures in Indonesia.
Fapon generates revenue through three streams: IVD raw materials sales to global IVD manufacturers as the primary revenue base, customized reagent services for assay development, and open-system instrument sales. Its economic model is built on an ecosystem approach — placing open-architecture analyzers (5,000+ globally) that allow partners to develop proprietary reagents, creating switching costs and recurring consumables demand. The company has supplied raw materials for 10+ billion COVID-19 tests and 200+ million malaria tests annually, supporting scale-based cost advantages. Pricing is negotiated on a B2B basis with multi-year contracts; no public pricing is disclosed.
The business is anchored by 1,200+ patent applications (450+ granted), 40% R&D headcount, and emerging scientific partnerships including Stanford Healthcare Innovation Lab and circRNA platform collaborations. The company operates a US R&D subsidiary in Lexington, MA (opened November 2023), and has pursued strategic partnerships with Roche Diagnostics China, Halodoc, Kalbe Farma, and Bio Farma to expand into new geographies. AI is used in biomarker discovery and bio-molecule design, though it functions as an internal R&D accelerator rather than a customer-facing product.
Fapon firmographics
Firmographics- Name
- Fapon
- Legal name
- Fapon Biotech Inc.
- Website
- https://en.faponbiotech.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Fapon Biotech is a Chinese IVD company founded in 2001 that provides a vertically integrated one-stop solution spanning raw materials, reagent services, and open-system instruments, serving 2,500+ IVD manufacturers and laboratories across 70+ countries through direct sales and channel partnerships.
- Ownership category
- akta.pro rank
Where Fapon is headquartered
LocationHeadquarters
- HQ city
- Dongguan
- HQ country
- China
- HQ region
- Asia
Offices5 records
Markets served
Fapon business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- IVD Raw Materials Sales: Sale of core IVD raw materials including antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers, and calibrators for CLIA, ELISA, rapid test, clinical chemistry, and molecular diagnostics platforms. This is Fapon's primary revenue stream, serving as a fundamental upstream supplier to IVD reagent manufacturers worldwide.
- IVD Reagent Services: Customized reagent development and manufacturing services for CLIA, high-throughput sequencing, quantitative fluorescence PCR (qPCR), and fluorescence-based lateral flow immunoassay. Provides semi-finished and finished bulk reagent solutions to IVD manufacturers.
- Open-System Instruments: Sale of open-architecture diagnostic instruments including the Shine i-Series chemiluminescence analyzers (i1000, i2000, i3000, i6000, i8000/9000, mT8000), Ideal 30 molecular diagnostic system, WS-Mi immunofluorescence analyzers, and Nous 30V veterinary analyzer. Instruments are sold to IVD manufacturers and laboratories.
- Licensing (PSP Biomarker): Exclusive license from LASCCO SA and Abionic SA to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. Fapon develops, manufactures, and commercializes PSP raw materials and CLIA-based reagent solutions, generating revenue through product sales in the licensed territory.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B raw materials and reagent services — pricing not publicly disclosed |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
Fapon product offering
Product offeringCore offering
Fapon Biotech is a global IVD upstream supplier providing a vertically integrated one-stop solution comprising (1) core raw materials — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators for CLIA, ELISA, rapid test, clinical chemistry and molecular diagnostics; (2) customized reagent development services for CLIA, NGS, qPCR and fluorescence lateral flow assays; and (3) open-system diagnostic instruments including the Shine i-Series chemiluminescence analyzers, Ideal/Nous molecular diagnostic systems, and WS-series immunofluorescence analyzers. The portfolio serves IVD reagent manufacturers, clinical laboratories, and emerging-market diagnostics companies across 70+ countries.
Product overview
Fapon is a leading global provider of IVD total solutions comprising three interconnected product lines: IVD raw materials (antigens, antibodies, diagnostic enzymes, and blockers), IVD reagent services (customized development for CLIA, NGS, qPCR, and fluorescence-based assays), and open-system instruments (Shine i-series chemiluminescence analyzers ranging from i1000 to mT8000, Ideal and Nous molecular diagnostic systems, and WS immunofluorescence analyzers). The company also offers specialized reagent solutions for specific disease areas including infectious diseases (HIV, malaria, mpox), cardiac markers (hs-cTnI), Alzheimer's disease biomarkers, and vitamin D testing. The portfolio is unified through an ecosystem approach where raw materials feed into reagent services which run on open instruments, enabling partners to develop complete diagnostic solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- IVD Raw Materials Core raw materials for in vitro diagnostics — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators — supplied to IVD reagent manufacturers across CLIA, ELISA, rapid test, clinical chemistry, and molecular diagnostics platforms. Over 1,300 product offerings across the line.
- IVD Reagent Services Customized reagent development and manufacturing services for CLIA, high-throughput sequencing (NGS), quantitative fluorescence PCR (qPCR), and fluorescence-based lateral flow immunoassay (FIA) applications. Delivers semi-finished and finished bulk reagent solutions to IVD manufacturers.
- Open-System Diagnostic Instruments Open instrument platforms — chemiluminescence, molecular POCT, fluorescence immunochromatography, and high-throughput gene sequencing analyzers — sold to IVD manufacturers and laboratories. Enables partners to develop and run proprietary reagents on Fapon analyzers.
- Shine i8000/9000 Fully Automatic Chemiluminescence Immunoassay Analyzer High-speed fully automatic chemiluminescence immunoassay analyzer with detection speed of 900 tests/hour, designed for mid- and high-volume laboratories. Compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
- Shine i6000 Fully Automatic Chemiluminescence Immunoassay Analyzer Automatic chemiluminescence immunoassay analyzer designed for medium-throughput laboratories, compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
- Shine i3000 Fully Automatic Chemiluminescence Immunoassay Analyzer Automatic chemiluminescence immunoassay analyzer for medium-throughput laboratories, compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
- Shine i2000 Fully Automatic Chemiluminescence Immunoassay Analyzer Compact, high-capacity chemiluminescence immunoassay analyzer compatible with AE, AP, HRP, and ABEI chemiluminescence protocols.
- Shine i1000 Fully Automatic Chemiluminescence Immunoassay Analyzer Smallest fully automatic chemiluminescence immunoassay analyzer in the Shine lineup, compatible with AE, AP, and HRP chemiluminescence protocols.
- Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System High-throughput clinical chemistry and immunoassay analyzer delivering complete workflow automation in a space-saving 5 m² footprint for mid- and high-volume laboratories.
- Ideal 30 Fully Automatic Molecular Diagnostic System Fully automatic molecular diagnostic system for human diagnostics combining magnetic bead-based nucleic acid extraction with quantitative fluorescence PCR (qPCR) for rapid results.
- Nous 30V Fully Automatic Molecular Diagnostic System for Veterinary Diagnostics Fully automatic molecular diagnostic system specifically designed for veterinary diagnostics applications.
- WS-Mi6000 Multi-Channel Immunofluorescence Analyzer Multi-channel fluorescent lateral flow reader designed for labs and departments in hospitals.
- WS-Si1500 Hand-Held Immunofluorescence Analyzer Hand-held immunofluorescence analyzer for point-of-care testing applications.
- WS-Si1000 Single-Channel Immunofluorescence Analyzer Single-channel immunofluorescence analyzer for point-of-care testing applications.
- FAtraction32 Nucleic Acid Extraction System Nucleic acid extraction system using magnetic bead separation technology for molecular diagnostics sample preparation.
- FAlight16 Rapid Real-time Fluorescent Quantitative PCR System Rapid real-time fluorescent quantitative PCR system using innovative liquid circulation refrigeration combined with unique Peltier temperature control technology.
- NGS Reagent Services Next-generation sequencing reagent services for women's health, men's health, children's health, reproductive health, pharmacogenetic testing, chronic diseases, cancers, and microbiome applications.
- FP MAP Protein-Free Blocker Protein-free blocking agent used in diagnostic immunoassay applications to reduce background noise and improve assay specificity.
- Mpox Antigen Diagnostic Solutions Diagnostic solutions for mpox (monkeypox) antigen detection, including raw materials and reagents for IVD manufacturers.
- HIV-P24 Raw Material for Early HIV Detection Fourth-generation HIV detection raw material targeting HIV-1/HIV-2 antibodies and P24 antigen. Reduces the detection window period to 2-3 weeks, detects major global HIV subtypes and circulating recombinant forms, with overall specificity exceeding 99.8%.
- TeloScript Reverse Transcriptase Reverse transcriptase enzyme for molecular diagnostics applications including cDNA synthesis and RT-qPCR workflows.
- AK Taq DNA Polymerase V2 Taq DNA polymerase enzyme used in PCR applications for molecular diagnostics.
- Alzheimer's Disease Blood Testing Solutions Complete set of raw materials and bulk reagents for Alzheimer's disease blood testing, covering core biomarkers p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. Demonstrates high sensitivity, specificity, and correlation to predicate kits.
- Pf-pLDH Malaria Raw Materials High-performance Plasmodium falciparum pLDH raw materials for malaria diagnosis with 10x higher sensitivity than conventional solutions; detection limit as low as 0.4 ng/mL, validated against NIBSC reference materials and CDC panels. No cross-reactivity with Pv-PLDH or Pf-HRPII.
- LAMP Solutions for Rapid Molecular Diagnostics Loop-mediated isothermal amplification (LAMP) raw material solutions for rapid molecular diagnostics workflows.
- High-Sensitivity cTnI Antibody Pairs (hs-cTnI) High-sensitivity cardiac troponin I (hs-cTnI) antibody pairs using chimeric (human-mouse), rabbit, sheep, and goat antibodies, achieving femtogram-scale sensitivity. R² 0.9928 in AE-based CLIA and 0.9902 in ALP-based CLIA within linear ranges.
- Total Vitamin D Double Reagent Solution for Whole Blood Double-reagent solution for quantitative detection of Vitamin D in human whole blood using latex immunoturbidimetry and the double antibody method. Correlation R² > 0.96 vs competitor turbidimetric reagent across 142 clinical samples.
- Double Antibody VD Reagent Solution (Biochemistry Platform) Liquid dual-reagent Vitamin D biochemistry platform product with double-antibody method, suitable for all brands of automatic biochemical analyzers.
- Chemiluminescence One-Stop Solution Comprehensive chemiluminescence solution bundling high-performance core raw materials, over 70 self-developed assays, and the Shine i-Series CLIA analyzers (i1000–i8000/9000, mT8000) for IVD manufacturers.
Quantifiable outcome
- hs-cTnI assay correlation (R²) reaches 0.9928 in AE-based CLIA within linear range (297 samples) and 0.9362 at concentrations < 0.1 ng/mL (141 samples)
- +9 more outcomes
Companies that use Fapon
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
Fapon technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature12 records
Fapon partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- PT Bio FarmacorePT Fapon and PT Bio Farma (Indonesia's state-owned pharmaceutical holding company) forged a strategic partnership to advance IVD localization and innovation in Indonesia. Bio Farma is a state-owned pharmaceutical holding company with extensive manufacturing and distribution infrastructure in Indonesia.
- PT Kalbe Farma TbkcoreFapon and PT Kalbe Farma (one of Southeast Asia's largest public pharmaceutical companies, established 1966) signed a Memorandum of Understanding (MoU) at MEDICA 2023 to deepen cooperation and boost Indonesia's IVD development. This builds on Fapon's existing partnerships in Indonesia and aims to accelerate local IVD manufacturing and market penetration.
- China Innovation Center (C.I.C.) at Dubai ChamberscoreFapon signed a Memorandum of Cooperation (MoC) with China Innovation Center at Dubai Chambers during the Dubai Business Forum 2023. The partnership aims to cultivate strategic partnerships in IVD, pharmaceuticals, therapeutics, biomarker screening, and healthcare-related investments to boost Dubai's healthcare industry. C.I.C. serves as a platform for Chinese tech companies to connect with GCC region clients.
- HalodoccoreFapon signed a strategic cooperation agreement with Halodoc, Indonesia's largest telehealth platform. The partnership establishes a joint venture to grow the IVD business and deliver high-quality diagnostic products in Indonesia. Fapon provides raw materials, reagent solutions, and open-instrument platforms; Halodoc leverages its sales channels, academia, and industry connections for market expansion.
- HalodoccorePrior to the formal joint venture announced in October 2023, Fapon and Halodoc had already established an initial partnership in October 2023 to drive the development of Indonesia's in-vitro diagnostics industry. This initial partnership preceded the formal joint venture structure.
- Stanford University Healthcare Innovation LabcoreFapon became an industry member of the Stanford University Healthcare Innovation Lab (HIL) Affiliates Program, led by Dr. Michael Snyder. This membership provides cutting-edge scientific insights and opportunities in precision medicine, including access to research in infectious disease, diabetes, cancer, cardiovascular disease, AI/ML, and multi-omics data. Fapon was also invited to join the Mental Healthcare Innovations Summit.
- Roche Diagnostics ChinacoreFapon Biotech entered a strategic partnership with Roche Diagnostics China at the 5th China International Import Expo (CIIE). The partnership encompasses close cooperation in raw material products and services, and molecular diagnostics. Both companies pool resources and combine strengths to jointly develop and improve one-stop solutions to meet local needs, accelerating R&D and translation of research results in the China IVD industry.
- LASCCO SA and Abionic SAcoreFapon entered an exclusive license agreement with two Swiss biotech companies LASCCO SA and Abionic SA to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. Fapon has rights to research, develop, manufacture, and commercialize PSP raw materials and CLIA-based reagent solutions within China. PSP immunoassay holds CE mark, Australian registration, and expected FDA 510(k) clearance.
- Halo Bio / Orna TherapeuticscoreFapon Group collaborates with Dr. Alex Wesselhoeft (founder of Halo Bio and co-founder of Orna Therapeutics) to develop state-of-the-art circular RNA technology platforms, including circRNA design and engineering platform, novel delivery systems, and innovative vaccines. This partnership addresses bottlenecks in circRNA industrialization.
Scale indicators13 records
Recent moves7 records
Expansion highlights5 records
Fapon competitors and assessment
Company assessmentEmerging players
- KingMed Diagnostics: KingMed Diagnostics operates the largest independent clinical laboratory network in China and increasingly develops proprietary IVD reagents and instruments, partially overlapping with Fapon's reagent services and clinical lab customer segment.
- Hangzhou AllTest Biotech: AllTest Biotech is a Chinese IVD company specializing in rapid diagnostic tests, infectious disease diagnostics, and lateral flow assays — an emerging player with partial overlap to Fapon's rapid test raw materials and reagent services.
Broad incumbents
- Bio-Rad Laboratories: Bio-Rad Laboratories is a global life sciences incumbent with IVD and research reagent businesses spanning quality controls, immunoassays, and digital PCR — a broad incumbent that competes with Fapon's molecular diagnostics and clinical chemistry reagent offerings.
- DiaSorin: DiaSorin is a global IVD incumbent specializing in immunodiagnostics and molecular diagnostics with the LIAISON CLIA platform — a broad incumbent with comparable specialty assay focus to Fapon's CLIA reagents and open-instrument approach.
- Roche Diagnostics: Roche Diagnostics is the global IVD leader with the cobas closed-system platform spanning immunoassays, clinical chemistry, and molecular diagnostics. As Fapon's strategic partner in China and a global competitor, Roche represents both customer and competitive benchmark.
- Mindray: Mindray is a global Chinese medical device and IVD incumbent with broad CLIA, hematology, and ultrasound offerings, plus an international distribution network spanning 190+ countries — a much larger broad incumbent competing with Fapon's instruments and reagent services globally.
Direct peers
- Beijing Strong Biotechnologies: Beijing Strong Biotechnologies develops IVD diagnostic reagents, instruments, and raw materials in China, with a focus on chemiluminescence immunoassays and clinical chemistry — directly overlapping with Fapon's CLIA and clinical chemistry raw materials business.
- Autobio Diagnostics: Autobio Diagnostics is one of China's largest listed IVD companies, producing immunoassay analyzers, reagents, and microbial diagnostics — a directly comparable vertically integrated Chinese IVD peer with similar global ambitions.
- Hybiome: Hybiome is a Chinese IVD raw materials and reagent manufacturer focused on chemiluminescence immunoassays, with a product portfolio spanning antigens, antibodies, and diagnostic instruments — directly comparable to Fapon's IVD raw materials and CLIA reagent offering.
- Shenzhen New Industries Biomedical (Snibe): Snibe is a leading Chinese IVD company manufacturing CLIA analyzers (MAGLUMI series) and reagents for clinical diagnostics. It competes with Fapon's Shine i-Series chemiluminescence instruments and reagent services in both domestic and overseas markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Fapon social profiles
Digital presenceFapon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fapon leadership team
Management profileNumber of profiles
Profiles6 records
Fapon subsidiaries and ownership
Company hierarchySubsidiaries4 records
Fapon funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fapon M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fapon
What does Fapon do?
Fapon Biotech is a global IVD upstream supplier providing a vertically integrated one-stop solution comprising (1) core raw materials — antigens, antibodies, diagnostic enzymes, recombinant proteins, blockers and calibrators for CLIA, ELISA, rapid test, clinical chemistry and molecular diagnostics; (2) customized reagent development services for CLIA, NGS, qPCR and fluorescence lateral flow assays; and (3) open-system diagnostic instruments including the Shine i-Series chemiluminescence analyzers, Ideal/Nous molecular diagnostic systems, and WS-series immunofluorescence analyzers. The portfolio serves IVD reagent manufacturers, clinical laboratories, and emerging-market diagnostics companies across 70+ countries.
Is Fapon a public or private company?
Fapon is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Fapon founded?
Fapon was founded in 2001. It employs 101 to 250 people.
Where is Fapon based?
Fapon is headquartered in Dongguan, China, in the Asia region.
How does Fapon make money?
Four revenue lines are on record. IVD Raw Materials Sales are the primary driver. The others are IVD Reagent Services, open-System Instruments and licensing (PSP Biomarker).
Who are Fapon's main competitors?
Emerging players on record are KingMed Diagnostics and Hangzhou AllTest Biotech. Broad incumbents are Bio-Rad Laboratories, DiaSorin, Roche Diagnostics and Mindray. Direct peers are Beijing Strong Biotechnologies, Autobio Diagnostics, Hybiome and Shenzhen New Industries Biomedical (Snibe).
Does Fapon have an API?
No public API is recorded for Fapon.